Nicolas Papillon
Chief Executive Officer en Orthopaedic & Spine Development SAS .
Perfil
Nicolas Papillon is the Chairman and Co-Chief Executive Officer of Orthopaedic & Spine Development SAS, which he founded in 2005.
He is currently a Director at Graftys SA. Previously, he was a Director and VP-Americas & Business Development at Implanet SA. Mr. Papillon received his undergraduate degree from SKEMA Business School in 2003.
Cargos activos de Nicolas Papillon
Empresas | Cargo | Inicio |
---|---|---|
Orthopaedic & Spine Development SAS
Orthopaedic & Spine Development SAS Medical SpecialtiesHealth Technology Part of Implanet SA, Orthopaedic & Spine Development SAS is a French company that manufactures implants for spine surgery. The private company is based in Avignon, France. The company was founded in 2005 by Nicolas Papillon. Nicolas Papillon has been the CEO since 2005. Orthopaedic & Spine Development was acquired by Implanet SA on May 18, 2021 for $3.65 million. | Chief Executive Officer | 01/01/2005 |
Graftys SA
Graftys SA Medical SpecialtiesHealth Technology Graftys SA designs, manufactures and markets calcium phosphate-based synthetic bone substitutes to the global orthopedic and dental surgery markets. Its research and development projects include injectable and resorbable synthetic bone substitutes, biological repair of cartilage and of the spine, as well as bone substitutes combined with pharmaceutical agents. The company was founded by Jean Marc Ferrier, Alain Valet, Jean-Michel Bouler and Aurélien Valet in September 2005 and is headquartered in Aix-en-Provence, France. | Director/Board Member | - |
Antiguos cargos conocidos de Nicolas Papillon.
Empresas | Cargo | Fin |
---|---|---|
IMPLANET SA | Director/Board Member | - |
Formación de Nicolas Papillon.
SKEMA Business School | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
IMPLANET SA | Health Technology |
Empresas privadas | 2 |
---|---|
Graftys SA
Graftys SA Medical SpecialtiesHealth Technology Graftys SA designs, manufactures and markets calcium phosphate-based synthetic bone substitutes to the global orthopedic and dental surgery markets. Its research and development projects include injectable and resorbable synthetic bone substitutes, biological repair of cartilage and of the spine, as well as bone substitutes combined with pharmaceutical agents. The company was founded by Jean Marc Ferrier, Alain Valet, Jean-Michel Bouler and Aurélien Valet in September 2005 and is headquartered in Aix-en-Provence, France. | Health Technology |
Orthopaedic & Spine Development SAS
Orthopaedic & Spine Development SAS Medical SpecialtiesHealth Technology Part of Implanet SA, Orthopaedic & Spine Development SAS is a French company that manufactures implants for spine surgery. The private company is based in Avignon, France. The company was founded in 2005 by Nicolas Papillon. Nicolas Papillon has been the CEO since 2005. Orthopaedic & Spine Development was acquired by Implanet SA on May 18, 2021 for $3.65 million. | Health Technology |
- Bolsa de valores
- Insiders
- Nicolas Papillon